BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35502895)

  • 1. METTL3 promotes homologous recombination repair and modulates chemotherapeutic response in breast cancer by regulating the EGF/RAD51 axis.
    Li E; Xia M; Du Y; Long K; Ji F; Pan F; He L; Hu Z; Guo Z
    Elife; 2022 May; 11():. PubMed ID: 35502895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.
    Zhang C; Chen L; Peng D; Jiang A; He Y; Zeng Y; Xie C; Zhou H; Luo X; Liu H; Chen L; Ren J; Wang W; Zhao Y
    Mol Cell; 2020 Aug; 79(3):425-442.e7. PubMed ID: 32615088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer.
    Li S; Jiang F; Chen F; Deng Y; Pan X
    J Biochem Mol Toxicol; 2022 Jan; 36(1):e22922. PubMed ID: 34964205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer.
    Ouyang D; Hong T; Fu M; Li Y; Zeng L; Chen Q; He H; Wen Y; Cheng Y; Zhou M; Zou Q; Yi W
    Breast Cancer Res; 2023 Feb; 25(1):19. PubMed ID: 36765397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.
    Wang H; Xu B; Shi J
    Gene; 2020 Jan; 722():144076. PubMed ID: 31454538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
    Ni Z; Sun P; Zheng J; Wu M; Yang C; Cheng M; Yin M; Cui C; Wang G; Yuan L; Gao Q; Li Y
    Cancer Res; 2022 May; 82(9):1789-1802. PubMed ID: 35502544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3/IGF2BP3-regulated m6A modification of HYOU1 confers doxorubicin resistance in breast cancer.
    Zhou S; Sheng L; Zhang L; Zhang J; Wang L
    Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130542. PubMed ID: 38103759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TOPORS-mediated RAD51 SUMOylation facilitates homologous recombination repair.
    Hariharasudhan G; Jeong SY; Kim MJ; Jung SM; Seo G; Moon JR; Lee S; Chang IY; Kee Y; You HJ; Lee JH
    Nucleic Acids Res; 2022 Feb; 50(3):1501-1516. PubMed ID: 35061896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elp1 facilitates RAD51-mediated homologous recombination repair via translational regulation.
    Chen WT; Tseng HY; Jiang CL; Lee CY; Chi P; Chen LY; Lo KY; Wang IC; Lin FJ
    J Biomed Sci; 2021 Nov; 28(1):81. PubMed ID: 34819065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β1-Integrin Impacts Rad51 Stability and DNA Double-Strand Break Repair by Homologous Recombination.
    Ahmed KM; Pandita RK; Singh DK; Hunt CR; Pandita TK
    Mol Cell Biol; 2018 May; 38(9):. PubMed ID: 29463647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of FGFR2-Signaling Attenuates a Homology-Mediated DNA Repair in GIST and Sensitizes Them to DNA-Topoisomerase II Inhibitors.
    Sergei B; Pavel D; Aigul G; Firyuza B; Ilmira N; Ilshat M; Aida A; Refat K; Natalia A; Elena S; Vera G
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31948066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel motif of Rad51 serves as an interaction hub for recombination auxiliary factors.
    Afshar N; Argunhan B; Palihati M; Taniguchi G; Tsubouchi H; Iwasaki H
    Elife; 2021 Jan; 10():. PubMed ID: 33493431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DNA-binding activity of USP1-associated factor 1 is required for efficient RAD51-mediated homologous DNA pairing and homology-directed DNA repair.
    Liang F; Miller AS; Tang C; Maranon D; Williamson EA; Hromas R; Wiese C; Zhao W; Sung P; Kupfer GM
    J Biol Chem; 2020 Jun; 295(24):8186-8194. PubMed ID: 32350107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
    Miao W; Chen J; Jia L; Ma J; Song D
    Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.
    Luo K; Li L; Li Y; Wu C; Yin Y; Chen Y; Deng M; Nowsheen S; Yuan J; Lou Z
    Genes Dev; 2016 Dec; 30(23):2581-2595. PubMed ID: 27941124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.
    Xie J; Ba J; Zhang M; Wan Y; Jin Z; Yao Y
    J BUON; 2021; 26(2):444-449. PubMed ID: 34076991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB.
    Wanna-Udom S; Terashima M; Lyu H; Ishimura A; Takino T; Sakari M; Tsukahara T; Suzuki T
    Biochem Biophys Res Commun; 2020 Mar; 524(1):150-155. PubMed ID: 31982139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid sensitizes breast cancer cells to hydroxyurea through inhibiting RPA2 hyperphosphorylation-mediated DNA repair pathway.
    Tian Y; Liu G; Wang H; Tian Z; Cai Z; Zhang F; Luo Y; Wang S; Guo G; Wang X; Powell S; Feng Z
    DNA Repair (Amst); 2017 Oct; 58():1-12. PubMed ID: 28837865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.
    Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.